[1] 中华医学会感染病学分会.终末期肝病合并感染诊治专家共识.中华肝脏病杂志,2018,26:568-578.
[2] 梁丽芬,周召刚,雷宇等.154例肝硬化失代偿期患者并发血流感染的临床分析.中国感染与化疗杂志,2016,16:262-266.
[3] Fernández J,Acevedo J,Wiest R,et al.Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.Gut,2018,67:1870-1880.
[4] Jalan R,Fernandez J,Wiest R,et al.Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol,2014,60:1310-1324.
[5] Bartoletti M,Giannella M,Lewis R,et al.A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. Clin Microbiol Infect,2018,24:546.e1-546.e8
[6] Johnson DH.Infections in cirrhosis.Infect Dis Clin North Am,2001,15:363-371.
[7] Klímová K,Padilla C,Ávila JC,et al.Epidemiology of bacterial infections in patients with liver cirrhosis Experience in a Spanish tertiary health center. Biomedica 2016;36:121-132.
[8] Xie Y,Tu B,Xu Z,et al.Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis.Sci Rep,2017,7:11482-11587.
[9] 赵宁,李智伟.肝硬化合并感染及抗菌药物治疗的研究现状. 实用药物与临床,2008,5:266-269.
[10] 涂波,刘素霞,吴丹等.肝硬化患者社区获得性革兰阴性杆菌血流感染的临床特征.中华肝脏病杂志,2018,26:23-27.
[11] 李生荣,尹华.重型肝炎和感肝炎肝硬化合并细菌感染的临床分析.宁夏医学,2008,30:905-906.
[12] Cho JH,Park KH,Kim SH,et al.Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis. Scand J Infect Dis,2007,39:697-702.
[13] 王顺,王永涛,贾征夫.肝硬化患者医院感染病原菌分类及耐药性分析. 中华医院感染学杂志,2013,23:5851-5853.
[14] 郭桐生,曲芬,毛远丽,崔恩博,鲍春梅,张菊玲.慢性肝病患者血培养分离菌分布特征及耐药谱研究. 内科急危重症杂志,2006,03:105-107. |
